Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
Experts
MoneyTalks: Why this portfolio manager is bullish on the most shorted lithium stock on the ASX
News
Traders’ Diary: Everything you need to get ready for the week ahead
ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys
News
ASX Large Caps: ASX up 3pc this week on miners’ rally, Rio reports air crash, and Domino’s falls 30pc
Experts
Commsec 2024 Outlook: Lithium, AI, cybersecurity – the biggest themes to watch for
News
ASX Large Caps: ASX closes flat to end first week of 2024 in red
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Experts
MoneyTalks: The Greatest Wealth is Health, says Morningstar’s Shane Ponraj and Virgil
Experts
Life of Brian: Weighting for opportunity
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Yoga = chill. Fact. And ASX health stocks up for second week
Experts
MoneyTalks: Has the ASX stock hunter James Gerrish been too bearish?
News
ASX Large Caps: CSL, Resmed, and Westpac led gainers; data shows Aussie economy is softening
News
ASX Large Caps: Local shares defy Wall Street, Newmont CDIs make ASX debut as Newcrest delists
Health & Biotech
ScoPo’s Powerplays: Who fancies a ‘MedWalk intervention’? Oh, and ASX healthcare stocks can’t catch a break
Health & Biotech
ASX Health Stocks: Earnings season is in full swing. We pick three highlights from the Health sector
News
ASX Small Caps Lunch Wrap: Who got the worst kind of welcome home last week?
Experts
